The Discounted Cash Flow (DCF) valuation of Acceleron Pharma Inc (XLRN) is (425.77) USD. With the latest stock price at 178.75 USD, the upside of Acceleron Pharma Inc based on DCF is -338.2%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.1% - 7.7% | 6.9% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (1,067.12) - (269.06) | (425.77) |
| Upside | -697.0% - -250.5% | -338.2% |